Pharma Bio World - May 2018
Get Pharma Bio World along with 8,000+ other magazines & newspapers
Try FREE for 7 days
Latest and past issues of 8,000+ magazines & newspapers
Digital Access. Cancel Anytime.1 Year$99.99 $49.99 Save 50%
Latest and past issues of 8,000+ magazines & newspapersDigital Access. Cancel Anytime.Get Pharma Bio World
Buy this issue $0.99
May 2018 issue Digital Access. 
Subscription plans are currently unavailable for this magazine. If you are a Magzter GOLD user, you can read all the back issues with your subscription. If you are not a Magzter GOLD user, you can purchase the back issues and read them.
- Magazine Details
- In this issue
Magazine Description
In this issue
What’s next for the pharmaceuticals Industry, amid digital disruption and rapid technology advances? The June issue of Pharma Bio World, themed on Pharma Innovation, explores ways the sector could shift in coming years.
Cancel Anytime [ No Commitments ]
Digital Only
Sustainability In Processing And Packaging Technology; Technological Solutions For Ecological Challenges
The article analyses current ways of the pharma industry to make for more sustainable packaging and manufacturing processes, from utilising biodegradable plastics and fibre-based packaging to integrating energy-saving process equipment into their manufacturing lines. Further, the article takes a deep dive into how connected industry solutions can help reduce and optimize energy consumption.
Pharma 4.0 - Impact Of IIOT In Pharmaceutical Manufacturing
With the growing number of medical ailments across the globe, the pharmaceutical industry will undoubtedly become more important than ever in the near future. There is a paradigm shift from the mass production of drugs to offering more customized and specialized drugs to a smaller group of patients and this is greatly expected to improve the effectiveness of treatments.
Digitalization Influences The Pharmaceutical Industry
Industry 4.0 is all about creating seamless connectivity in between machines, processes, and people within and beyond manufacturing facilities to increase quality, productivity and profit by using the power of advanced data analytics.
Can Indian Traditional Medicinal Systems Show The Way Forward?
Indian traditional codified medicinal systems and folk medicine are a vast lexicon of herbal formulations and medicinal plants. In last few decades, the popularity of herbal medicine/ products has increased worldwide, not only as part of conventional treatment strategies but also for health care management, and thus the opportunity to promote Indian traditional medicine is increasing globally. Recently people from several developed and developing countries have been attracted toward traditional Indian herbal medicines. A large number of modern medicines are derived from the plants used in Ayurveda and other traditional medicinal systems. Ayurveda and other traditional herbal medicines are capable of addressing some modern unmet medical needs, and can provide the basis for developing potential medicines. Lack of drug standardization, information, quality control, and strict monitoring are the primary lacunae in the promotion of traditional Indian herbal products. In recent years several regulatory and promotional approaches have been undertaken to overcome such problems. Quality control, rigorous research to establish the effectiveness and safety, and credible clinical trials of the herbal products are required. Thus, the careful and scientific integration of Indian traditional herbal medicine into evidence-based clinical management of diseases is essential to provide better health care facilities to people.
Only About 5% Of Rare Diseases Have Treatments
Orphan drugs, those medications that are typically produced in small quantities for limited patient populations, are growing in importance worldwide.
Phytopharmaceuticals - Fighting Disease With Natural Substances
Phytopharmaceuticals are herbal medicines whose efficacy is down to one or several plant substances or active ingredients. They have been used for treating diseases since time immemorial. This traditional knowledge is still the basis for many medicinal products made from plants or parts thereof.
Analysis On The Issues Raised By The Regulatory Authorities On Indian Pharma Companies And Inputs Provided By Them
Pharmaceutical industry across the globe bench marks the standard of regulatory processes carried out by Food and Drug Administration of USA (USFDA). India which has th e highest number of USFDA approved plants outside of USA itself, has been confronted with slew of warning letters and import alerts from the said regulatory authority, which especially were accentuated during last six years i.e. from FY13-FY18. The current article delineates upon analysis on classification of violations cited by FDA for Indian Pharma cos, inputs provided by them while concluding with solutions to overcome majority of the regulatory observations.
Rational Use Of Drugs And Irrational Drug Combinations
Irrational use of medicines is a global phenomenon. Rational use of drugs may be defined as: Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and the lowest cost to them and their community. Overuse, polypharmacy and incorrect use of drugs are the most common problems of drug use today. Irrational use of drugs may result due to various reasons at various levels including the prescribing errors and over the counter drugs. Irrational use of medicines may lead to serious negative health and economic consequences. Many irrational drug combinations are available in the Indian market. Proper implementation of rational use of drugs will improve the quality of life and result in better community healthcare.
Cold Chain Management For Sensitive Goods
Packaging, route planning and risk analysis ensure safe conditions during transportation of delicate drugs. Drugs are sensitive goods to transport, which can be subject to irreversible damage if they are stored or transported at temperatures outside the tolerated range. If the temperature falls below or rises above the specified range the quality of drugs requiring refrigeration can be seriously affected and they may cease to be effective. This article therefore describes how transport conditions during the transportation of drugs can be optimised through suitable packaging, individualised process design, the analysis and assessment of potential risks and close collaboration between the sender and the freight carrier.
Vaccine Production Via Mammalian Cell Culture Systems
Mammalian cell culture systems are starting to dominate the production of vaccines for viral diseases such as rabies. Making use of existing biopharma infrastructure, these advances might even spell the end for the use of hens’ eggs in future vaccine development.
